Biopharmaceutical Aspects of Lipid Formulations of Amphotericin B

Research output: Contribution to journal › Article › Academic › peer-review

28 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	64-73
Number of pages	10
Journal	European Journal of Clinical Microbiology & Infectious Diseases
Volume	16
Issue number	1
DOIs	https://doi.org/10.1007/BF01575123
Publication status	Published - 1997

Research programs

@article{e8b1b84834984c88af8f9ba1ed513988,

title = "Biopharmaceutical Aspects of Lipid Formulations of Amphotericin B",

author = "G Storm and \{van Etten\}, \{EWM (Els)\}",

year = "1997",

doi = "10.1007/BF01575123",

language = "Undefined/Unknown",

volume = "16",

pages = "64--73",

journal = "European Journal of Clinical Microbiology \& Infectious Diseases",

issn = "0934-9723",

publisher = "Springer Science+Business Media",

number = "1",

}

TY - JOUR

T1 - Biopharmaceutical Aspects of Lipid Formulations of Amphotericin B

AU - Storm, G

AU - van Etten, EWM (Els)

PY - 1997

Y1 - 1997

U2 - 10.1007/BF01575123

DO - 10.1007/BF01575123

M3 - Article

SN - 0934-9723

VL - 16

SP - 64

EP - 73

JO - European Journal of Clinical Microbiology & Infectious Diseases

JF - European Journal of Clinical Microbiology & Infectious Diseases

IS - 1

ER -